Skip to content

Article: Nicotinamide Riboside Inhibits CD38 in Living Cells: Preclinical Findings

Nicotinamide Riboside Inhibits CD38 in Living Cells: Preclinical Findings


Synopsis

Nicotinamide adenine dinucleotide (NAD+) is essential for energy production, metabolism, and cell signaling, but its levels naturally decline with age and disease. One key reason for this decline is the enzyme CD38, which breaks down NAD+. This study revealed a surprising new function of nicotinamide riboside (NR)—a well-known vitamin B3–derived NAD+ precursor. Researchers discovered that NR not only helps build NAD+ but also directly inhibits CD38, preventing NAD+ degradation. NR does this by forming a stable chemical bond with a key amino acid (glutamate 226) in the CD38 enzyme’s active site. The team also created a modified “clickable” NR molecule that can label and visualize CD38 in live cells, offering a new tool to study its role in health and disease. These findings reveal that NR helps preserve NAD+ levels through dual actions—boosting production and blocking breakdown—opening new possibilities for therapeutic applications in aging, metabolism, and immune regulation.

Journal

JACS Au

Read more

Preclinical

Nicotinamide Riboside Preserves Oocyte Quality and Prevents Postovulatory Aging: Preclinical Findings

Synopsis After ovulation, oocytes (eggs) begin to age, leading to lower fertilization success and embryo quality during assisted reproductive technologies (ART) such as IVF. This process, known as...

Read more
Mitochondrial Health

Nicotinamide Riboside Protects Brain Development from Drug Toxicity: Preclinical Findings

Synopsis This study explored the potential neurodevelopmental risks of oseltamivir phosphate (OSE)—a widely used antiviral drug also found in the environment—using zebrafish models. Researchers di...

Read more